echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Eur Respir J: Intravenous methylprednisolone pulses can be used as a treatment for severely hospitalized patients with COVID-19

    Eur Respir J: Intravenous methylprednisolone pulses can be used as a treatment for severely hospitalized patients with COVID-19

    • Last Update: 2021-07-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    There is no definitive treatment of severe COVID-19 drug


    COVID-19 immunity

    The study included severely hospitalized patients in the early lung stage of COVID-19 diagnosed in Iran.


     

    From April 20, 2020 to June 20, 2020, 68 eligible patients received randomized treatment (34 patients in each group)


    In summary, the results of the study show that methylprednisolone pulse can be an effective treatment for hospitalized patients with severe COVID-19 in the lung stage


     

    Original source:

     

    Maryam Edalatifard, Maryam Akhtari, et al.


    Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial

    in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.